Rebound activation of coagulation after treatment with unfractionated heparin and not with low molecular weight heparin is associated with partial depletion of tissue factor pathway inhibitor and antithrombin

By Hansen J.-B.   Naalsund T.   Sandset P.M.   Svensson B.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 413-417

Elsevier

Access to resources Recommend Favorite

Antithrombin-Independent Anticoagulation by Hypersulfated Low-Molecular-Weight Heparin

By Fredenburgh J.C.   Anderson J.A.M.   Weitz J.I.  

Trends in Cardiovascular Medicine, Vol. 12, Iss. 7, 2002-10 ,pp. : 281-287

Elsevier

Access to resources Recommend Favorite

Reduction of Factor FVIIa Activity During Heparin Therapy - Evidence for Assay Interactions with Tissue Factor Pathway Inhibitor and Antithrombin

By Hansen J.-B.   Svensson B.   Sandset P.M.   Thijssen F.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 389-396

Elsevier

Access to resources Recommend Favorite

Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits

By Tazawa S.   Ichikawa K.   Misawa K.   Fukuyama J.   Hamano S.   Miyata H.   Sakuragawa N.  

Thrombosis Research, Vol. 80, Iss. 5, 1995-12 ,pp. : 391-398

Elsevier

Access to resources Recommend Favorite

The Binding of Unfractionated Heparin and Low Molecular Weight Heparin to Thrombin-Activated Human Endothelial Cells - Identification by morphological and immunological criteria

By Young E.   Venner T.   Ribau J.   Shaughnessy S.   Hirsh J.   Podor T.J.  

Thrombosis Research, Vol. 96, Iss. 5, 1999-12 ,pp. : 373-381

Elsevier

Access to resources Recommend Favorite